Clinical Trial Update: A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas [Phase 1]

View source ↗

Summary

A Phase I clinical trial evaluating indenoisoquinolines LMP400 and LMP776 in adults with relapsed solid tumors and lymphomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• LMP-400 (LMP-400)
• LMP-776 (LMP-776)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms, Lymphoma | Phase 1 | Status: COMPLETED